The U.S. Food And Drug Administration announced Tuesday that they are authorizing an additional batch of the Johnson & Johnson coronavirus vaccine produced at Emergent BioSolutions.
The U.S. Food And Drug Administration announced Tuesday that they are authorizing an additional batch of the Johnson & Johnson coronavirus vaccine produced at Emergent BioSolutions.